Navigation Links
Outsourcing clinical trials to India

Clinical research in India costs has become very easy and cheap compared to other countries, which has lead to an increased outsourcing of clinical research to India.

Outsourcing in the field of IT can be taken as a boom to the economics and development of India, but Outsourcing in // clinical trials is a great havoc to India, as humans are becoming a source of experimental animals and being exploited.

Due to intensive and strict Animal guidelines using animals in India too has become a very problem, so the drug companies have shifted their trials to humans rather to animals.

India has a rich man power of very skilled and intelligent research and development scientists and also has a great population of people with many diseases and the non exposure of these people to drugs make them more interesting for the drug companies to test their new drugs.

India has 30 million people in India have heart diseases, 25 million have type-II diabetes and 10 million suffer psychiatric disorders, and notes recruits in India are more likely to comply fully with the trial processes. An other important reason for considering India for clinical trial is availability of man power at a comparatively cheaper salaries, it is estimated that 20-30 percent of cost is saved by hiring clinical researchers, nurses and IT staff from India in addition to costs associated with patients.

The report also says India's newly adopted guidelines on "good clinical practices" and "patient consent norms" are in line with global rules, while saying commentators have also questioned consent from illiterate patients.

Source: Indo-Asian News Service
'"/>




Page: 1

Related medicine news :

1. Outsourcing Medical Records Risky: Unison
2. Lab Tests And Diagnostics - Next Wave Of Outsourcing
3. GlaxoSmithKline Signs Outsourcing Deal With TCS
4. Outsourcing Farming, a Chinese Initiative
5. Outsourcing of UK Hospital Records to India Opposed
6. How do patients benefit of clinical trials
7. Magnetic resonance angiography in clinical medicine
8. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
9. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
10. India to maintain Public domain Registry database of clinical trials conducted in India.
11. Diagnosis of Alzheimers years before clinical signs emerge
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
Breaking Medicine Technology: